1. Home
  2. OSIS vs DYN Comparison

OSIS vs DYN Comparison

Compare OSIS & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OSI Systems Inc. (DE)

OSIS

OSI Systems Inc. (DE)

HOLD

Current Price

$236.68

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$25.86

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSIS
DYN
Founded
1987
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
OSIS
DYN
Price
$236.68
$25.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
14
Target Price
$302.83
$37.00
AVG Volume (30 Days)
170.4K
2.6M
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
5.71
N/A
Revenue
$1,089,286,000.00
N/A
Revenue This Year
$9.74
N/A
Revenue Next Year
$5.53
N/A
P/E Ratio
$39.50
N/A
Revenue Growth
13.35
N/A
52 Week Low
$197.27
$9.89
52 Week High
$311.72
$26.62

Technical Indicators

Market Signals
Indicator
OSIS
DYN
Relative Strength Index (RSI) N/A 63.41
Support Level N/A $16.00
Resistance Level N/A $26.62
Average True Range (ATR) 0.00 1.47
MACD 0.00 -0.02
Stochastic Oscillator 0.00 87.27

Price Performance

Historical Comparison
OSIS
DYN

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: